Skip to content

Study of Blood Platelets in Sickle Cell Disease

Studies of Large Platelets in Patients With Sickle Cell Disease

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00226083
Enrollment
0
Registered
2005-09-26
Start date
2005-08-31
Completion date
2007-09-30
Last updated
2015-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Brief summary

We are studying if sickle cell disease blood platelets are larger than normal and how they may cause obstruction of blood vessels. We are also trying to study the reasons why large platelets are found in patients with sickle cell disease.

Detailed description

Research volunteers are seen in the Outpatient Research Center by the Principal Investigator or another physician. A detailed history is obtained, a physical examination is performed, and blood (usually 4 tablespoons) is obtained for additional tests. The research volunteer's previous medical records will be requested. Upto 5 additional blood samples may be obtained in a subgroup of patients.

Interventions

None listed

Sponsors

Icahn School of Medicine at Mount Sinai
CollaboratorOTHER
Schneider Children's Hospital of North Shore
CollaboratorOTHER
Rockefeller University
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults and children \> 7 years of age with sickle cell disease (Hb SS) who are not taking hydroxyurea and are not receiving routine blood transfusion therapy.

Exclusion criteria

* Current hydroxyurea therapy or, * Hydroxyurea use within the past 3 months * Blood transfusion or exchange transfusion within the past 3 months * Current treatment with aspirin or clopidogrel

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026